Demand for the drug, Remdesivir, which may bring a faster recovery from COVID-19 infections, is increasing, as were demands for the government to increase its availability.:
It has been approved for use in Jamaica:
Ministry of Health and Wellness will procure the drug:
The ministry’s statement is below:
It notes ‘In Jamaica, while we await full registration approval in the country of origin, the drug can be used under the controls of a study or under an emergency license.’
The ministry has issued a number of emergency permits for the importation of the drug. This requires a letter from the prescribing physician indicating the need for this drug and including recognition of the responsibility for prescribing an unapproved drug as well as the consent of the patient to take an unapproved drug, the statement said.
Further, the ministry said it has stipulated that the prescribing and administering of the drug comply with the following conditions:
• Informed consent must be obtained;
• That inventory control systems be put in place at the facilities to ensure that records of the dispensed product and patient information are maintained — similar to that used for controlled substances;
•That the drug be administered to hospitalised patients who are closely monitored;
• That serious adverse events must be tracked and reported to the Pharmacovigilance Unit of the Standards and Regulations Division of the ministry, using the PharmWatch Drug Monitoring Form, located on the ministry website.